Skip to content
DraconiticResearch
Search Sources API
186,625 studies31 sourcesUpdated 46 min ago
Peer-reviewedCC BY-NC-NDThe World Allergy Organization journal

Long-term prophylaxis for hereditary angioedema: Navigating the switch between therapies☆

  • Aleena Banerji1
  • Jonathan A. Bernstein2
  • Laurence Bouillet3
  • Paula J. Busse4
  • Mauro Cancian5
  • Danny M. Cohn6
  • Timothy Craig7
  • Mar Guilarte8
  • William R. Lumry9
  • Markus Magerl10
  • Cristine Radojicic11
  • Avner Reshef12
2 more authors
  • Marc A. Riedl13
  • Raffi Tachdjian14
14 affiliations
  1. 1Division of Allergy and Clinical Immunology, Department of Medicine, Massachusetts General Brigham, Harvard Medical School, Boston, MA, USA
  2. 2Division of Rheumatology, Allergy, and Immunology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA
  3. 3T-RAIG Unit, CNRS, UMR, University of Grenoble Alpes, CHU Grenoble Alpes, TIMC, Grenoble, 5525, France
  4. 4Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA
  5. 5Department of Systems Medicine, University Hospital of Padua, Padua, Italy
  6. 6Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
  7. 7Departments of Medicine, Pediatrics, Obstetrics and Gynecology, Maternal-Fetal Medicine, and Biomedical Sciences, Penn State University, Hershey, PA, USA
  8. 8Department of Allergy, Hospital Universitari Vall d'Hebron, Vall d’Hebron Research Institute (VHIR), Barcelona, Spain
  9. 9Asthma and Allergy Research Associates, Dallas, TX, USA
  10. 10Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universitätsmedizin Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
  11. 11Duke Health, Durham, NC, USA
  12. 12Allergy, Immunology, and Angioedema Center, Barzilai University Hospital, Ashkelon, Israel
  13. 13Division of Allergy and Immunology, University of California San Diego School of Medicine, La Jolla, CA, USA
  14. 14Division of Allergy, Immunology, and Rheumatology, University of California Los Angeles, Los Angeles, CA, USA
Read full textPDFCite

Related

  1. Experiences From the First Year of Using Garadacimab to Treat Hereditary Angioedema and Acquired Angioedema
    Markus Magerl, Kathrin Schön, Janine Ruhe +3
    Clinical and translational allergyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Adverse health outcomes and patient and physician perspectives of attenuated androgen use in hereditary angioedema☆
    Markus Magerl, Anete S. Grumach, Noemi Fluetsch Brennan +8
    The World Allergy Organization journalPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Hereditary Angioedema with Normal C1-Inhibitor in Children: Diagnostic Challenges, Novel Mutations in MYOF, F12, and HS3ST6, and the Role of Bioinformatics Analysis
    Anita R. Denisova, Natalia G. Kolosova, Natalia A. Geppe +7
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Human geneticsCrossref
  4. Periprocedural management of patients with hereditary angioedema undergoing coronary angiography and percutaneous coronary intervention
    Michał Tarnowski, Paulina Brania, Iwona Gorczyca-Głowacka +1
    Postepy w kardiologii interwencyjnej = Advances in interventional cardiologyPeer-reviewedCC BY-NC-SAFull textHuman geneticsEurope PMCPMC
  5. Garadacimab in Hereditary Angioedema: Modeling Suggests Sustained Improvements in Attack-Free Probability and Quality of Life Over 5 Years.
    Philip H Li, F Ida Hsu, Emel Aygören-Pürsün +7
    Clinical and translational sciencePeer-reviewedCC BY-NCFull textHuman geneticsEurope PMC

Cite

BibTeXRIS
BibTeX
@article{banerji2026longterm,
  title = {{Long-term prophylaxis for hereditary angioedema: Navigating the switch between therapies☆}},
  author = {Aleena Banerji and Jonathan A. Bernstein and Laurence Bouillet and Paula J. Busse and Mauro Cancian and Danny M. Cohn and Timothy Craig and Mar Guilarte and William R. Lumry and Markus Magerl and Cristine Radojicic and Avner Reshef and Marc A. Riedl and Raffi Tachdjian},
  journal = {The World Allergy Organization journal},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13676735},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Long-term prophylaxis for hereditary angioedema: Navigating the switch between therapies☆
AU  - Aleena Banerji
AU  - Jonathan A. Bernstein
AU  - Laurence Bouillet
AU  - Paula J. Busse
AU  - Mauro Cancian
AU  - Danny M. Cohn
AU  - Timothy Craig
AU  - Mar Guilarte
AU  - William R. Lumry
AU  - Markus Magerl
AU  - Cristine Radojicic
AU  - Avner Reshef
AU  - Marc A. Riedl
AU  - Raffi Tachdjian
PY  - 2026
DA  - 2026/09/22
JO  - The World Allergy Organization journal
UR  - https://europepmc.org/article/PMC/PMC13676735
SN  - 1939-4551
ER  -